Cholestasis gravidarum in women in the second and third trimester of gestation, clinical and specific pharmacological treatment and its benefits
DOI:
https://doi.org/10.62486/agsalud202336Keywords:
Pruritus, Jaundice, Fetal Distress, Deliveries and ControlsAbstract
Introduction: cholestasis gravidarum is a syndrome that usually occurs in pregnant women in the second or third trimester of pregnancy and ends in the puerperium. It is clinically characterized by the presence of predominantly nocturnal pruritus that is palmoplantar at first and then generalized. Alterations in liver function with or without jaundice and elevated serum bile acid levels, biochemical cholestasis is classified as mild to moderate in severity.
This pathology does not have significant consequences for the mother, but it is associated with a high risk of affecting the newborn, such as premature delivery, fetal distress, fetal arrhythmias and intrauterine death.
Objective: diagnostic methods and behaviors in their pharmacological treatments that provide the best results for those patients.
Methods: systematic review with qualitative database from the PUBMED platform. The articles were downloaded from the PUBMED platform and Zotero was used to make the proper citations and references. In the investigation, the population will be composed of adult female patients who were admitted to any health care unit during the second and third trimesters.
Results: the PUBMED database was used with the following MESH terms (cholestasis of pregnancy) that generated 2 597 results. 28 articles were analyzed in more depth, of which 12 articles were finally selected for the final analysis. Ursodeoxycholic acid (UDCA), a beta epimer of chenodeoxycholic acid, is a more polar bile acid than primary bile acids, with substantial choleretic and multiple other chemoprotective effects. The mechanism of action is not fully understood, but studies have shown that after treatment there is a reduction in total serum bile acids in both maternal and umbilical cord serum and a qualitative change in bile acid pool. serum. When compared to all controls, UDCA was also found to be associated with a decreased incidence of preterm birth, neonatal respiratory distress, and the number of neonatal intensive care unit admissions
References
(1) Sentilhes, L.; Bacq, Y. La cholestase intrahépatique gravidique. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 2008, 37 (2), 118–126. https://doi.org/10.1016/j.jgyn.2006.09.007.
(2) Gabzdyl, E. M.; Schlaeger, J. M. Intrahepatic Cholestasis of Pregnancy: A Critical Clinical Review. Journal of Perinatal & Neonatal Nursing 2015, 29 (1), 41–50. https://doi.org/10.1097/JPN.000000000000007 7.
(3) Pusl, T.; Beuers, U. Intrahepatic Cholestasis of Pregnancy. Orphanet J Rare Dis 2007, 2 (1), 26. https://doi.org/10.1186/1750-1172-2-26.
(4) Shao, Y.; Chen, S.; Li, H.; Tang, Q.; Xu, D. Maternal Bile Acid Profile and Subtype Analysis of Intrahepatic Cholestasis of Pregnancy. Orphanet J Rare Dis 2021, 16 (1), 259. https://doi.org/10.1186/s13023-021-
01887-1.
(5) Wood, A. M.; Livingston, E. G.; Hughes, B. L.; Kuller, J. A. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management. Obstetrical & Gynecological Survey 2018, 73 (2), 103–109. https://doi.org/10.1097/OGX.00000000000005 24.
(6) Smith, D. D.; Rood, K. M. Intrahepatic Cholestasis of Pregnancy. Clinical Obstetrics & Gynecology 2020, 63 (1), 134–151. https://doi.org/10.1097/GRF.00000000000004 95.
(7) Dixon, P. H.; Williamson, C. The Pathophysiology of Intrahepatic Cholestasis of Pregnancy. Clinics and Research in Hepatology and Gastroenterology 2016, 40 (2), 141–153. https://doi.org/10.1016/j.clinre.2015.12.008.
(8) Bicocca, M. J.; Sperling, J. D.; Chauhan,
S. P. Intrahepatic Cholestasis of Pregnancy: Review of Six National and Regional Guidelines. European Journal of Obstetrics & Gynecology and Reproductive Biology 2018, 231, 180–187. https://doi.org/10.1016/j.ejogrb.2018.10.041.
(9) Šimják, P.; Pařízek, A.; Vítek, L.; Černý, A.; Adamcová, K.; Koucký, M.; Hill, M.; Dušková, M.; Stárka, L. Fetal Complications Due to Intrahepatic Cholestasis of Pregnancy. Journal of Perinatal Medicine 2015, 43 (2). https://doi.org/10.1515/jpm-2014-0089.
(10) Kong, X.; Kong, Y.; Zhang, F.; Wang, T.; Yan, J. Evaluating the Effectiveness and Safety of Ursodeoxycholic Acid in Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta- Analysis (a Prisma-Compliant Study). Medicine 2016, 95 (40), e4949. https://doi.org/10.1097/MD.000000000000494 9.
(11) Shao, Y.; Chen, S.; Li, H.; Tang, Q.; Xu, D. Maternal Bile Acid Profile and Subtype Analysis of Intrahepatic Cholestasis of Pregnancy. Orphanet J Rare Dis 2021, 16 (1), 259. https://doi.org/10.1186/s13023-021-
01887-1
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Logran Nobre Da Silva , Marcelo Adrian Estrin (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
